LIVN
LivaNova PLC
NASDAQ: LIVN · HEALTHCARE · MEDICAL DEVICES
$60.10
+2.00% today
Updated 2026-04-30
Market cap
$3.51B
P/E ratio
—
P/S ratio
2.53x
EPS (TTM)
$-4.45
Dividend yield
—
52W range
$35 – $72
Volume
0.9M
LivaNova PLC (LIVN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-17.50%
Operating margin
13.00%
ROE
-19.20%
ROA
5.17%
Debt/equity
0.42x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $130.97M | $-51.18M | 86.06% | -37.82% | -39.08% |
| 2007 | $121.23M | $-10.33M | 82.60% | -6.79% | -8.52% |
| 2008 | $143.60M | $26.72M | 86.04% | 13.22% | 18.61% |
| 2009 | $167.78M | $78.45M | 87.54% | 21.97% | 46.76% |
| 2010 | $190.46M | $46.73M | 87.91% | 25.83% | 24.53% |
| 2011 | $218.50M | $36.08M | 91.00% | 27.89% | 16.51% |
| 2012 | $254.32M | $46.36M | 91.39% | 30.81% | 18.23% |
| 2013 | $282.01M | $54.89M | 90.30% | 28.37% | 19.46% |
| 2014 | $282.01M | $54.89M | 90.30% | 28.37% | 19.46% |
| 2015 | $291.56M | $57.85M | 90.63% | 30.41% | 19.84% |
| 2016 | $1.21B | $-62.80M | 58.03% | -2.27% | -5.17% |
| 2017 | $1.01B | $-25.10M | 64.37% | 9.45% | -2.48% |
| 2018 | $1.11B | $-189.40M | 66.35% | -22.41% | -17.11% |
| 2019 | $1.08B | $-157.64M | 66.76% | -15.82% | -14.54% |
| 2020 | $934.24M | $-348.82M | 63.66% | -29.32% | -37.34% |
| 2021 | $1.04B | $-135.82M | 68.19% | -0.08% | -13.12% |
| 2022 | $1.02B | $-86.25M | 69.21% | -7.51% | -8.44% |
| 2023 | $1.15B | $17.55M | 66.86% | -5.94% | 1.52% |
| 2024 | $1.25B | $63.23M | 69.48% | 10.30% | 5.04% |
| 2025 | $1.39B | $-242.50M | 67.71% | 14.36% | -17.47% |